Please find enclosed herewith Intimation with respect to Appointment Internal Auditor of the company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Accretion Nutraveda reported strong FY2025-26 results with revenue of ₹3,360.31 Lakhs (up 110% from ₹1,600.18 Lakhs) and net profit of ₹506.83 Lakhs (up 103% from ₹250.09 Lakhs). EPS improved to ₹9.35 from ₹6.88. Two independent directors resigned citing personal and professional commitments: Mr. Arun Dash and Mr. Mahipal Singh Chouhan. The company appointed two new independent directors - Mr. Chand Rameshbhai Kanabar and Ms. Grishma A Shewale - subject to shareholder approval. The board also approved appointment of M/s. U M T & Co. as internal auditor and re-appointed M/s. Sakhiya & Co. as secretarial auditor. The company listed on BSE SME in February 2026 via IPO raising ₹2,476.80 Lakhs, with ₹655.48 Lakhs still unutilized.
The dual resignation of independent directors raises governance concerns despite new appointments being made. The strong financial performance and recent IPO listing are positives, but investors should monitor board composition and ensure shareholder approval for new directors.